Get started
EEE

EMCURE PHARMACEUTICALS L

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

EMCURE chart


Full chart

EMCURE upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪246.97 B‬ INR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪4.98 B‬ INR
Revenue (FY)
‪65.92 B‬ INR
Shares float
‪25.55 M‬
Beta (1Y)
0.99

About EMCURE PHARMACEUTICALS L


Sector
Health Technology
CEO
Satish Ramanlal Mehta
Headquarters
Pune
Website
emcure.com
Founded
1981
ISIN
INE168P01015
FIGI
BBG004SL4F06
Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. It focuses on therapeutic areas, such as the gynecology, cardiovascular, Vitamins, minerals and nutrients, Anti-invectives, gastrointestinal, blood related oncology/anti-neoplastics, HIV, neurology, respiratory and anti-diabetic therapeutic areas. The company offers a wide range of products and services under Formulations, Biologics and Active Pharmaceutical Ingredients. It produces pharmaceutical and biopharmaceutical products of a range of dosage forms, including oral solids, oral liquids, injectables including lipid, liposomal, lyophilized injectables, biologics, vaccines and complex APIs, including chiral molecules and cytotoxic products. Emcure Pharmaceuticals was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

EMCURE news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of EMCURE is 1,283.80 INR — it has decreased by −1.76% in the past 24 hours. Watch EMCURE PHARMACEUTICALS L stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange EMCURE PHARMACEUTICALS L stocks are traded under the ticker EMCURE.
EMCURE stock has fallen by −5.18% compared to the previous week, the month change is a −11.53% fall, over the last year EMCURE PHARMACEUTICALS L has showed a −3.11% decrease.
We've gathered analysts' opinions on EMCURE PHARMACEUTICALS L future price: according to them, EMCURE price has a max estimate of 1,680.00 INR and a min estimate of 1,580.00 INR. Watch EMCURE chart and read a more detailed EMCURE PHARMACEUTICALS L stock forecast: see what analysts think of EMCURE PHARMACEUTICALS L and suggest that you do with its stocks.
EMCURE reached its all-time high on Sep 18, 2024 with the price of 1,580.00 INR, and its all-time low was 1,225.00 INR and was reached on Aug 13, 2024. View more price dynamics on EMCURE chart.
See other stocks reaching their highest and lowest prices.
EMCURE stock is 3.63% volatile and has beta coefficient of 0.99. Track EMCURE PHARMACEUTICALS L stock price on the chart and check out the list of the most volatile stocks — is EMCURE PHARMACEUTICALS L there?
Today EMCURE PHARMACEUTICALS L has the market capitalization of ‪246.97 B‬, it has decreased by −2.08% over the last week.
Yes, you can track EMCURE PHARMACEUTICALS L financials in yearly and quarterly reports right on TradingView.
EMCURE PHARMACEUTICALS L is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
EMCURE net income for the last quarter is ‪1.95 B‬ INR, while the quarter before that showed ‪1.44 B‬ INR of net income which accounts for 35.04% change. Track more EMCURE PHARMACEUTICALS L financial stats to get the full picture.
No, EMCURE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EMCURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EMCURE PHARMACEUTICALS L stock right from TradingView charts — choose your broker and connect to your account.